Serpina3n deficiency exacerbates sepsis‐induced myocardial dysfunction by disrupting fibroblast–cardiomyocyte crosstalk
Clinical and Translational Medicine · 2026-11 · 16 (11)
DOI: 10.1002/ctm2.70898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 14.11.2026. Verfasst von Xunuo Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Fibroblasts, Myocytes, Cardiac, Sepsis, Serpins. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis‐induced myocardial dysfunction (SIMD) is a key contributor to death among individuals with sepsis. Serpina3n (a serine protease inhibitor) contributes critically to various cardiovascular diseases. However, whether Serpina3n is involved in SIMD and its underlying mechanisms remain unclear.
Methods
A SIMD model was established by either an intraperitoneal injection of lipopolysaccharide (LPS) or caecal ligation and puncture (CLP) in mice. Single‐cell RNA sequencing (scRNA‐seq) was carried out to examine Serpina3n expression and its cellular localisation in mouse hearts. Serpina3n expression was also examined in LPS‐treated neonatal mouse cardiac fibroblasts (NMCFs) and neonatal mouse cardiomyocytes (NMCMs). Global Serpina3n knockout (KO) (Serpina3n −/− ) and fibroblast‐specific Serpina3n‐deficient (Serpina3n flox/flox , Col1a2‐iCre) mouse models were used for functional validation in vivo.
Results
Serpina3n expression was notably up‐regulated in the hearts of SIMD mice, and it was enriched mainly in cardiac fibroblasts (CFs). Consistent with the scRNA‐seq data, Serpina3n expression was markedly increased in LPS‐treated NMCFs but not in NMCMs. Furthermore, both global Serpina3n KO and fibroblast‐specific Serpina3n deletion exacerbated cardiac inflammation and dysfunction, facilitated the progression of SIMD and ultimately increased mortality. Mechanistically, LPS stimulation promoted the secretion of Serpina3n from CFs, which acted on cardiomyocytes (CMs) in a paracrine manner, thereby attenuating the expression of proteins related to the Janus kinase/signal transducer and activator of transcription signalling pathway and reducing cardiac inflammatory cell infiltration to ultimately exert a cardioprotective effect. These processes were disrupted by fibroblast‐specific Serpina3n deficiency.
Conclusions
Collectively, these findings indicate that CF‐derived Serpina3n mediates CF–CM crosstalk and plays an essential protective role in SIMD, providing mechanistic insights and a potential candidate target for further preclinical investigations of SIMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Xunuo Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Yan, Y., Kong, A., Li, X., Xie, H., Hu, Z., & Zuo, G. (2026). Serpina3n deficiency exacerbates sepsis‐induced myocardial dysfunction by disrupting fibroblast–cardiomyocyte crosstalk. Clinical and Translational Medicine, 16(11). https://doi.org/10.1002/ctm2.70898
Vancouver
Wang X, Yan Y, Kong A, Li X, Xie H, Hu Z, et al. Serpina3n deficiency exacerbates sepsis‐induced myocardial dysfunction by disrupting fibroblast–cardiomyocyte crosstalk. Clinical and Translational Medicine. 2026;16(11). doi:10.1002/ctm2.70898
BibTeX
@article{Wang2026,
author = {Wang, Xunuo and Yan, Yufeng and Kong, Aiqing and Li, Xiya and Xie, Hao and Hu, Zuoying and Zuo, Guangfeng},
title = {Serpina3n deficiency exacerbates sepsis‐induced myocardial dysfunction by disrupting fibroblast–cardiomyocyte crosstalk},
journal = {Clinical and Translational Medicine},
year = {2026},
volume = {16},
number = {11},
doi = {10.1002/ctm2.70898}
}
EUVIMED